HEJDUK, Karel, Petr BRABEC, Zbyněk BORTLÍČEK and Daniel KLIMEŠ. TULUNG - Iressa: stav registru k datu 30. 9. 2013 (TULUNG - Iressa: state of the registry as of 30/9/2013). Brno: neuveden, 2013, 40 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name TULUNG - Iressa: stav registru k datu 30. 9. 2013
Name (in English) TULUNG - Iressa: state of the registry as of 30/9/2013
Authors HEJDUK, Karel (203 Czech Republic, belonging to the institution), Petr BRABEC (203 Czech Republic, guarantor, belonging to the institution), Zbyněk BORTLÍČEK (203 Czech Republic, belonging to the institution) and Daniel KLIMEŠ (203 Czech Republic, belonging to the institution).
Edition Brno, 40 pp. 2013.
Publisher neuveden
Other information
Original language Czech
Type of outcome Research report
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/13:00075384
Organization unit Faculty of Medicine
Keywords in English lung cancer; NSCLC; clinical registry
Changed by Changed by: Mgr. Jakub Gregor, Ph.D., učo 16577. Changed: 25/7/2014 12:36.
Abstract
Registr TULUNG je neintervenční poregistreační databáze zaměřená na sběr epidemiologických a klinických dat pacientů s diagnózou nemalobuněčného karcinomu plic (NSCLC) léčených cílenou léčbou v České republice. Zpráva přináší aktuální analýzu pacientů s karcinomem ledvin léčených gefitinibem.
Abstract (in English)
The TULUNG registry is a non-interventional post-registration database focused on the collection of epidemiological and clinical data of patients with non-small cell lung carcinoma (NSCLC) who have been treated with targeted therapy in the Czech Republic. The report brings recent analysis of renal cell carcinoma patients treated with gefitinib.
PrintDisplayed: 6/10/2024 14:20